Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Terminated(1)

Detailed Status

Completed2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
66.7%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

terminated133%
completed267%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Neurally Targeted Cognitive Training to Augment CBT Outcomes in Pediatric Anxiety

NCT04157296
completednot_applicable

Integral Remediation for Major Depression ("Rehabilitación Integral Para la Depresión Mayor", RIDEM)

NCT03624621
terminatednot_applicable

Augmenting rTMS With Cognitive Control Training in Major Depressive Disorder

NCT04317495

Clinical Trials (3)

Showing 3 of 3 trials
NCT04157296Not Applicable

Neurally Targeted Cognitive Training to Augment CBT Outcomes in Pediatric Anxiety

Completed
NCT03624621Not Applicable

Integral Remediation for Major Depression ("Rehabilitación Integral Para la Depresión Mayor", RIDEM)

Completed
NCT04317495Not Applicable

Augmenting rTMS With Cognitive Control Training in Major Depressive Disorder

Terminated

All 3 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
3